Tugce Munise Satir
Tugce Munise Satir
1Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-405 30 Gothenburg, Sweden
1,✉,
Faisal Hayat Nazir
Faisal Hayat Nazir
1Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-405 30 Gothenburg, Sweden
2Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-431 80 Mölndal, Sweden
1,2,
Dzeneta Vizlin-Hodzic
Dzeneta Vizlin-Hodzic
1Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-405 30 Gothenburg, Sweden
1,
Erik Hardselius
Erik Hardselius
2Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-431 80 Mölndal, Sweden
2,
Kaj Blennow
Kaj Blennow
2Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-431 80 Mölndal, Sweden
3Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, S-431 80 Mölndal, Sweden
2,3,
Selina Wray
Selina Wray
4Department of Neurodegenerative Disease, Institute of Neurology, University College London Queen Square, London, WC1N 3BG UK
4,
Henrik Zetterberg
Henrik Zetterberg
2Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-431 80 Mölndal, Sweden
3Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, S-431 80 Mölndal, Sweden
4Department of Neurodegenerative Disease, Institute of Neurology, University College London Queen Square, London, WC1N 3BG UK
5UK Dementia Research Institute at UCL, London, WC1E 6BT UK
2,3,4,5,
Lotta Agholme
Lotta Agholme
1Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-405 30 Gothenburg, Sweden
1,#,
Petra Bergström
Petra Bergström
1Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-405 30 Gothenburg, Sweden
1,#
1Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-405 30 Gothenburg, Sweden
2Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, S-431 80 Mölndal, Sweden
3Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, S-431 80 Mölndal, Sweden
4Department of Neurodegenerative Disease, Institute of Neurology, University College London Queen Square, London, WC1N 3BG UK
5UK Dementia Research Institute at UCL, London, WC1E 6BT UK
© The Author(s) 2020
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
